Roflumilast to Treat Cognitive Sequela After Stroke

Summary

The aim of the current project is to validate the effects of chronic rolflumilast treatment (12 weeks) on cognitive functions (i.e. episodic memory) by means of behavioral tasks, in people suffering from cognitive impairments at least 1 year after stroke. Secondarily, the effects of roflumilast on daily activities and well-being will be assessed.

Timeline

Start

2021-07-07

Primary completion

2023-12-01

Completion

2023-12-01

Drugs

Indications